Article

OTC MEVACOR GETS THUMBS DOWN AGAIN-January 2008

Merck & Co Inc's third bid

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Kannapat | stock.adobe.com
Image credit: adragan | stock.adobe.com
Related Content
Close up of rheumatism / arthritis medical examination.
August 29th 2025

New Nanoparticle Treatment Shows Promise for Preventing Rheumatoid Arthritis Flares

Kennedy Ferruggia, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
August 29th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
FDA approves REMS modification for sparsentan -- Image credit: wladimir1804 | stock.adobe.com
August 29th 2025

FDA Approves REMS Modification for Sparsentan in IgA Nephropathy

Gillian McGovern, Associate Editor
Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage
August 29th 2025

Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage

Jennifer Griffin, PharmD, MS Luke Halpern, Assistant Editor
Isolated horizontal image of GLP-1 Semaglutide therapy injection pens - Image credit: Shutterly | stock.adobe.com
August 29th 2025

FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss

Kennedy Ferruggia, Assistant Editor
Empty pharmacy shelves | Image Credit: © Oleksandr - stock.adobe.com
August 29th 2025

Long-Lasting Drug Shortages Highlight Fragile Supply Chains and Systemic Market Pressures

Alexandra Gerlach, Associate Editor